ClinVar Miner

Submissions for variant NM_006005.3(WFS1):c.2039A>C (p.Glu680Ala)

gnomAD frequency: 0.00050  dbSNP: rs144840779
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins NTD LLC (GA) RCV000725856 SCV000339960 uncertain significance not provided 2018-09-07 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine,Mass General Brigham Personalized Medicine RCV000354766 SCV000711254 uncertain significance not specified 2017-12-21 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Benign. The p.Glu680Ala var iant in WFS1 has not been previously reported in individuals with hearing loss, but has been identified in 0.21% (51/24020) of African chromosomes by the Genome Aggregation Database (gnomAD,; dbSNP rs1448407 79). Although this variant has been seen in the general population, its frequenc y is not high enough to rule out a pathogenic role. Computational prediction too ls and conservation analysis suggest that the p.Glu680Ala variant may not impact the protein, though this information is not predictive enough to rule out patho genicity. In summary, while the clinical significance of the p.Glu680Ala variant is uncertain, available data suggest that it is more likely to be benign. ACMG/ AMP Criteria applied: BP4.
Personalized Diabetes Medicine Program,University of Maryland School of Medicine RCV000664092 SCV000787544 uncertain significance Monogenic diabetes 2017-06-26 criteria provided, single submitter research ACMG Criteria:PP3 (9 predictors) NOTE: Emory calls VUS in ClinVar 4/2016
Invitae RCV000725856 SCV001092077 likely benign not provided 2021-11-13 criteria provided, single submitter clinical testing
GeneDx RCV000725856 SCV001768360 uncertain significance not provided 2021-08-24 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.